Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Softechie who wrote (2026)	10/2/1999 11:08:00 AM
From: Softechie	Read Replies (1) \| Respond to of 2068

OXFORD HEALTH PLANS (OXHP: $17.63)@* 09/17/99 Upbeat Presentation at DLJ Conference Earnings Per Share Old New P/E Ratios (FY:Dec.) 2000E $1.10 $ 16.0 1999E 0.18 97.9 1998A (4.10) -4.3 Rating: TOP PICK Change: None 12-Mo. Target: $27 We continue to rate Oxford Health Plans Top Pick based on strong turnaround momentum that should drive the stock higher; and exceptional brand franchise that could result in a premium take-out value for the company as the financial recovery proceeds. Dr. Payson's presentation at the DLJ Growth Stock Conference detailed the ongoing turnaround progress and laid out some new pricing and cost control initiatives that should bolster 2000 prospects. This confirms our belief that Oxford is now at an inflection point, with EPS and cash flow poised to turn nicely positive. Investors attending the session seemed quite impressed with the investment opportunity, and the lively Q&A suggested keen interest in the stock. The earnings turnaround coupled with widening investor interest should provide nice support for the stock.